



Total Synthesis of Neurymenolide A Based on a Gold-Catalyzed
Synthesis of 4-Hydroxy-2-pyrones**




General. All reactions were carried out in flame-dried glassware under Argon. All solvents were 
purified by distillation over the drying agents indicated and were transferred under Argon: THF (Mg-
anthracene), diethyl ether (Mg-anthracene), dichloromethane (CaH2), acetonitrile (CaH2), 
triethylamine (CaH2), hexane (Na/K), toluene (Na/K). HOAc and MeOH were used as received. Flash 
chromatography: Merck silica gel 60 (230-400 mesh). IR: Nicolet FT-7199 spectrometer, 
wavenumbers in cm−1. MS (EI): Finnigan MAT 8200, MS (CI): Finnigan MAT 95, MS (ESI) ESQ 3000; 
accurate mass determinations: Bruker APEX III FT-MS (7 T magnet). NMR: Spectra were recorded on 
a Bruker DPX 300, AV 400 or AV 500 spectrometer in the solvents indicated; 1H and 13C chemical 
shifts (δ) are given in ppm relative to TMS, coupling constants (J) in Hz. The solvent signals were used 
as references (CDCl3 H = 7.24 ppm, C = 77.0 ppm; C6D6 H = 7.15 ppm, C = 128.00 ppm; [D6]-DMSO 
H = 2.50 ppm, C = 39.5 ppm; D3COD H = 3.31 ppm, C = 49.00 ppm) and the chemical shifts 
converted to the TMS scale. Unless stated otherwise, all commercially available compounds (ABCR, 
Acros, Aldrich, Fluka, Lancaster, Strem) were used as received. 
 
New Gold-Catalyzed Synthesis of 4-Hydroxy-2-pyrones. Pseudopyronine A 
 
Compound 6g (R1 = hexyl, R2 = pentyl). t-Butyl octanoate (1.0 g, 0.5 mmol) was added dropwise to a 
stirred solution of LDA (0.5 M in THF, 10 mL, 5 mmol) at –78 °C. The mixture 
was stirred at this temperature for 30 min before methyl 2-octynoate (771 
mg, 0.5 mmol) was slowly introduced and stirring continued at –78 °C for 2 
h. The mixture was poured into aq. sat. NH4Cl (50 mL) and the organic phase 
extracted with Et2O (3 x 50 mL), dried (Na2SO4) and concentrated. Flash chromatography of the 
residue (silica, hexanes/EtOAc, 99:1 → 95:5) gave keto ester 6g as a colorless oil (1.34 g, 83 %). 1H 
NMR (400 MHz, CDCl3, mixture of keto/enol tautomers): δ  0.85-0.93 (m, 6H), 1.23-1.43 (m, 12H), 
1.46 & 1.50 (s each,  9H), 1.53-1.62 (m, 2H), 1.80-1.93 (m, 1H), 2.22-2.29 (m, 1H), 2.36 (t, J = 7.1, 
1H), 2.40 (t, J = 7.1, 1H), 3.33 (t, J = 7.4, 0.5H), 12.33 (s, 0.5H); 13C NMR (100 MHz, CDCl3): δ  13.8, 
13.9, 14.0, 14.0, 19.0, 19.4 22.0, 22.1, 22.5, 22.6, 27.0, 17.3, 27.8, 27.8, 27.9, 28.1, 28.2, 28.9, 29.0, 
29.6, 30.9, 31.0, 31.5, 31.6, 61.9, 75.0, 79.6, 81.6, 81.7, 96.3, 99.2, 109.4, 152.3, 168.2, 172.8, 183.3. 
IR (film): ~  = 2957, 2929, 2859, 2214, 1736, 1677, 1633, 1598, 1457, 1369, 1358, 1250, 1150, 1128, 
845, 820; MS (EI): m/z (%) 322 (4), 266 (45), 249 (15), 238 (5), 223 (23), 210 (13), 195 (23), 177 (20), 
139 (11), 123 (95), 98 (71), 82 (9), 67 (23), 57 (100), 41 (38); HRMS (EI): m/z: calcd for C20H34O3Na 
[M+Na]: 345.24001, found: 345.23988. 
Representative Procedure for the Preparation of 4-Hydroxy-2-pyrones. Synthesis of 
Pseudopyronine A (7g). A solution of substrate 6g (325 mg, 1.0 mmol) and 
SPhosAuNTf2 (8) (9 mg, 10 µmol, 1 mol%) in HOAc (5 mL) was stirred for 24 h 
before the acid was distilled off and the residue purified by flash 
chromatography (silica, hexane/HOAc, 4:1) to afford pseudopyronine A (7g) 
as a white solid (257 mg, 96 %). Mp = 111.5-112.5 °C (lit. 106-108 °C).1 1H 
NMR (400 MHz, CDCl3): δ  0.86-0.93 (m, 6H), 1.24-1.38 (m, 10H), 1.44-1.54 (m, 2H), 1.58-1.68 (m, 
2H), 2.40-2.48 (m, 4H), 6.20 (s, 1H), 10.19 (br s, 1H); 13C NMR (100 MHz, CDCl3): δ  13.9, 14.1, 22.3, 
22.7, 23.1, 26.5, 28.0, 29.3, 31.1, 31.8, 33.5, 100.9, 103.4, 163.6, 167.2, 168.4; 1H NMR (400 MHz, 
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CD3OD): δ  0.89 (t, J = 7.0, 3H), 0.92 (t, J = 7.0, 3H), 1.32-1.40 (m, 10H), 1.40-1.50 (m, 2H), 1.60-1.70 
(m, 2H), 2.37 (t, J = 7.5, 2H), 2.46 (t, J = 7.6, 2H), 4.89 (br s, 1H), 5.98 (s, 1H); 13C NMR (100 MHz, 
CD3OD): δ  14.2, 14.4, 23.4, 23.7, 23.9, 27.6, 29.0, 30.2, 32.2, 32.9, 34.2, 101.0, 103.9, 165.1, 167.7, 
168.8; IR (film): ~  = 2955, 2926, 2872. 2858, 2643, 1663, 1630, 1556, 1433, 1407, 1292, 1256, 1172, 
1130, 992, 856, 758; MS (EI): m/z (%) 266 (17), 249 (3), 237 (3), 223 (11), 209 (14), 195 (100), 182 (9), 
168 (19), 153 (10), 140 (15), 126 (11), 111 (7), 99 (11), 83 (4), 69 (10), 55 (21), 43 (21); HRMS (ESI–): 
m/z: calcd for C16H25O3 [M-H]
–: 265.18092, found: 265.18085. 
 
Figure S1. Analysis of the 1H NMR data of compounds 7a and 7c (6-endo product) and comparison 
with known data for the tetronic acid (5-exo product) established their structures. 
 
Compound 7a. Prepared analogously as colorless crystals (655 mg, 94%); after washing with Et2O, the 
material was found analytically pure, thus requiring no flash chromatography. Mp  
106–107 °C (lit:2a 83 °C); 1H NMR (400 MHz, CDCl3): δ  11.33 (br s, 1 H), 6.02 (dt, J  2.0, 
1.0 Hz, 1 H), 5.59 (d, J  2.0 Hz, 1 H), 2.52 (q, J  7.5 Hz, 2 H), 1.20 (t, J  7.5 Hz, 3 H); 13C 
NMR (100 MHz, CDCl3): δ  172.9 (C), 168.5 (C), 168.3 (C), 100.6 (CH), 89.7 (CH), 26.8 (CH2), 10.8 
(CH3); IR (film): 
~  = 2984, 2950, 2566, 1650, 1614, 1574, 1543, 1446, 1383, 1366, 1311, 1283, 1266, 
1242, 1203, 1139, 937, 883, 835, 808, 782, 693, 661 cm1; MS (EI): m/z (%): 140 (37) [M], 111 (70), 
99 (16), 69 (100), 57 (26), 29 (24); HRMS (EI): m/z: calcd for C7H8O3 [M
]: 140.0473, found: 140.0472. 
The spectroscopic data are in good agreement with the data reported in the literature.2 
Compound 7b. Prepared analogously as a white solid (14.9 mg, 97%); after washing with Et2O, the 
material was found analytically pure, thus requiring no flash chromatography. 1H NMR 
(400 MHz, [D6]-DMSO): δ  11.08 (br s, 1 H), 5.96 (br s, 1 H), 2.43 (q, J  7.5 Hz, 2 H), 
1.74 (s, 3 H), 1.09 (t, J  7.5 Hz, 3 H); 13C NMR (100 MHz, [D6]-DMSO): δ  165.0 (C), 
164.9 (C), 163.8 (C), 98.2 (CH), 96.5 (C), 25.9 (CH2), 10.9 (CH3), 8.3 (CH3); IR (film): 
~  = 2984, 2967, 
2914, 2690, 1671, 1634, 1574, 1508, 1428, 1399, 1373, 1353, 1315, 1238, 1180, 1122, 1088, 1056, 
1020, 947, 930, 845, 831, 752, 743, 667 cm1; MS (EI): m/z (%): 154 (88) [M], 126 (79), 111 (100), 99 
(59), 83 (14), 69 (94); HRMS (EI): m/z: calcd for C8H10O3 [M
]: 154.0630, found: 154.0631. 
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Compound 7c. Prepared analogously as a white solid (18.7 mg, 99%); after washing with Et2O, the 
material was found analytically pure, thus requiring no flash chromatography. 1H NMR 
(400 MHz, [D6]-DMSO): δ  11.85 (br s, 1 H), 7.84 (m, 2 H), 7.51 (m, 3 H), 6.75 (d, J  1.9 
Hz, 1 H), 5.40 (d, J  1.9 Hz, 1 H); 13C NMR (100 MHz, [D6]-DMSO): δ  170.5 (C), 163.0 
(C), 160.1 (C), 131.1 (C), 130.9 (CH), 129.1 (2  CH), 125.5 (2  CH), 98.4 (CH), 89.6 (CH) ppm. The 
analytical data matched those reported in the literature.2a,3 
Compound 7d. Prepared analogously as a white solid (18.6 mg, 82%); after washing with Et2O, the 
material was found analytically pure, thus requiring no flash chromatography. Mp = 
187-195 °C (decomp.); 1H NMR (400 MHz, [D6]-DMSO): δ  1.11 (t, J = 7.5, 3H), 2.48 (dq, 
J = 7.5, 0.8, 2H), 6.08 (t, J = 0.8, 1H), 12.53 (br s, 1H); 13C NMR (100 MHz, [D6]-DMSO): δ 
 10.7, 25.7, 84.9, 98.2, 160.4, 165.8, 166.7; IR (film): ~  = 3082, 1656, 1565, 1428, 1411, 1380, 1326, 
1222, 1157, 1048, 971, 943, 844, 791, 773, 741, 683; MS (EI): m/z (%) 220 (96), 218 (97), 192 (53), 
190 (57), 177 (15), 175 (16), 163 (21), 161 (22), 135 (36), 133 (35), 122 (12), 120 (11), 111 (8), 99 
(100), 83 (11), 69 (25), 57 (30), 53 (29), 39 (12), 29 (27); HRMS (EI): m/z: calcd for C7H6O3Br [M+Na
]: 
216.95059, found: 216.95071. 
Compound 7e. Prepared analogously as a white solid (17.5 mg, 85%); after washing with Et2O, the 
material was found analytically pure, thus requiring no flash chromatography. 1H NMR 
(400 MHz, [D6]-DMSO): δ  12.38 (br s, 1 H), 7.78 (m, 2 H), 7.51 (m, 3 H), 6.83 (d, J  5.3 
Hz, 1 H); 13C NMR (100 MHz, [D6]-DMSO): δ  157.1 (d, JCF  23.7 Hz, C), 154.9 (d, JCF  6.0 
Hz, C), 153.8 (d, JCF  9.2 Hz, C), 133.0 (C), 130.7 (CH), 130.4 (C), 129.1 (2  CH), 125.3 (2  CH), 98.9 
(CH); IR (film): ~  = 2885, 2641, 2587, 2551, 1625, 1577, 1549, 1495, 1453, 1399, 1356, 1174, 1071, 
1048, 910, 859, 824, 770, 734, 685, 658 cm1; MS (EI): m/z (%): 206 (100) [M], 178 (27), 149 (21), 130 
(18), 105 (42), 77 (53), 51 (27); HRMS (ESI): m/z: calcd for C11H7O3FNa [M
  Na]: 229.0271, found: 
229.0274. 
Compound 7f. Prepared analogously as a white solid (8.3 mg, 45%). Mp = 116-118 °C; 1H NMR (400 
MHz, CDCl3): δ  0.27 (s, 9H), 5.66 (d, J = 2.3, 1H), 6.36 (d, J = 2.3, 1H), 11.00 (br s, 1H); 
13C NMR (100 MHz, CDCl3): δ  –2.9, 92.5, 112.1, 169.7, 170.1, 175.1; IR (film): 
~
 = 3133, 2961, 1681, 1650, 1631, 1571, 1421, 1283, 1243, 1222, 1188, 1088, 988, 921, 
869, 839, 826, 702; MS (EI): m/z (%) 184 (22), 169 (81), 156 (2), 143 (10), 127 (6), 111 (6), 99 (20), 83 
(8), 73 (100), 69 (21), 66 (3), 55 (4), 45 (16), 29 (3); HRMS (EI): m/z: calcd for C8H12O3Si [M+Na
]: 
184.05558, found: 184.05542. 
Compound 7h. Prepared analogously as a yellow solid (26.2 mg, 98%); after washing with Et2O, the 
material was found analytically pure. Because of the low solubility, flash 
chromatography results in loss of material. Mp = 239-242°C (decomp.); 1H NMR 
(400 MHz, [D6]-DMSO): δ  5.30 (d, J = 2.0, 1H), 6.07 (s, 2H), 6.13 (d, J = 1.8, 
1H), 6.88 (d, J = 16.0, 1H), 6.95 (d, J = 8.0, 1H), 7.14 (dd, J = 8.1, 1.4, 1H), 7.23 (d, 
J = 16.0, 1H), 7.33 (d, J = 1.4, 1H), 11.69 (br s, 1H); 13C NMR (100 MHz, [D6]-
DMSO): δ  89.6, 101.1, 101.4, 106.0, 108.5, 118.0, 123.6, 129.7, 133.9, 148.0, 148.4, 159.4, 162.9, 
170.1; IR (film): ~  = 1699, 1631, 1606, 1555, 1499, 1479, 1443, 1357, 1299, 1254, 1241, 1157, 1100, 
1036, 1009, 959, 924, 840, 815, 796, 683; MS (EI): m/z (%) 258 (100), 241 (7), 230 (6), 214 (21), 199 
(11), 188 (45), 175 (30), 160 (25), 145 (25), 130 (16), 117 (16), 102 (12), 89 (35), 77 (6), 69 (26), 51 
(10), 39 (11), 29 (5); HRMS (EI): m/z: calcd for C14H10O5Na [M+Na
]: 281.04204, found: 281.04205. 
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2-(Benzyloxy)-6-ethyl-2H-pyran-4-one (10). Prepared analogously as a white solid (21.6 mg, 94%). 
Mp = 75-76 °C; 1H NMR (400 MHz, CDCl3): δ  1.21, (t, J = 7.5, 3H), 2.51 (dt, J = 7.5, 
0.5, 2H), 5.09 (s, 2H), 5.54 (d, J = 1.8, 1H), 5.99 (m, J = 1.8, 1H), 7.35-7.44 (m, 5H); 1H 
NMR (400 MHz, CDCl3): δ  10.7, 26.2, 71.2, 90.9, 111.1, 127.9, 128.9, 129.0, 133.7, 
166.4, 167.1, 181.9; IR (film): ~  = 3051, 2973, 2914, 1656, 1615, 1589, 1575, 1500, 
1455, 1416, 1380, 1366, 1302, 1251, 1226, 103, 1157, 1091, 1059, 1029, 1005, 978, 924, 898, 800, 
787, 740, 691, 681, 670; MS (EI): m/z (%) 230 (1) 174 (1), 132 (15), 91 (100), 77 (1), 65 (9), 51 (1), 40 
(3), 29 (2) HRMS (EI): m/z: calcd for C14H14O3Na [M+Na
]: 253.08351, found: 253.08334. 
 
Total Synthesis of Neurymenolide A 
 
(Z)-1-(Trimethylsilyl)oct-5-en-1-yn-3-ol (12). n-BuLi (1.6 M in hexane, 32 mL, 51 mmol) was added 
slowly to a stirred solution of ethynyltrimethylsilane (7.8 mL, 55 mmol) in THF (50 
mL) at –78 °C. After stirring at this temperature for 30 min, freshly distilled (Z)-3-
hexenal (3.6 g, 36.7 mmol, Z:E  85:15) was added dropwise and stirring 
continued for 30 min at –78°C before the cooling bath was removed and the mixture stirred at 
ambient temperature for 1 h. The solution was poured into aq. sat. NH4Cl (100 mL), and the aqueous 
layer extracted with Et2O (3 x 50mL), the combined organic layers dried (Na2SO4) and concentrated in 
vacuo. Flash chromatography of the residue (silica gel, hexanes/EtOAc, 98:2 → 95:5) gave product 12 
(6.1 g, 84%). 1H NMR (400 MHz, CDCl3): δ  0.17 (s, 9H), 0.98 (t, J = 7.5, 3H), 1.8 (br s, 1H), 2.03-2.14 
(m, 2H), 2.44-2.50 (m, 2H), 4.38 (t, J = 6.2, 1H), 5.38-5.47 (m, 1H), 5.57-5.66 (m, 1H). 13C NMR (100 
MHz, CDCl3): δ  –0.2, 14.2, 20.8, 35.5, 62.4, 89.5, 106.2, 122.7, 135.9; IR (film): 
~  = 3341, 3013, 
2962, 2176, 1456, 1407, 1334, 1305, 1249, 1125, 1041, 1002, 961, 886, 838, 759, 698; MS (EI): m/z 
(%) 196 (1), 181 (22), 167 (10), 151 (5), 127 (81), 122 (7), 99 (100), 91 (12), 83 (7), 75 (37), 55 (16), 41 
(19), 29 (6); HRMS (EI): m/z: calcd for C11H20OSi [M
]: 196.12834, found: 196.12817. Characteristic 
signals of the E-isomer: 13C NMR (100 MHz, CDCl3): δ  –0.3, 13.7, 25.7, 40.9, 137.2. 
(Z)-1-Oct-5-en-1-yn-3-ol (13). K2CO3 (5 g, 36 mmol) was added to solution of compound 12 (3.40 g, 
17.3 mmol) in methanol (50 mL) and the suspension stirred for 30 min. The mixture 
was poured into aq. sat. NH4Cl (100 mL), the aqueous layer extracted with Et2O (3 x 
50mL), and the combined organic phases dried (Na2SO4) and concentrated in vacuo. 
Flash chromatography of the residue (silica, pentane/Et2O, 9:1 → 4:1) gave product 13 as a colorless 
oil (2.10 g, 98%). 1H NMR (400 MHz, CDCl3): δ  0.98 (t, J = 7.5, 3H), 1.78 (br s, 1H), 2.05-2.14 (m, 2H), 
2.46 (d, J = 2.1, 1H) 2.48-2.52 (m, 2H), 4.40 (dt, J = 6.2, 2.1, 1H), 5.40-5.49 (m, 1H), 5.60-5.68 (m, 1H). 
13C NMR (100 MHz, CDCl3): δ 14.2, 20.8, 35.4, 61.8, 72.9, 84.4, 122.3, 136.2; IR (film): 
~  = 3325 (br), 
3297, 3013, 2964, 2934, 2875, 1456, 1405, 1304, 1122, 1037, 969, 867, 795; MS (EI): m/z (%): 124 
(0.2), 109 (12), 95 (23), 91 (26), 70 (38), 69 (35), 67 (35), 55 (62), 53 (15), 41 (100); Characteristic 
signals of the E-isomer: 1H NMR (400 MHz, CDCl3): δ  1.00 (t, J = 7.3), 2.40-2.45 (m), 4.37 (dt, J = 6.0, 
2.1). 
(1E,5Z)-1-(Tributylstannyl)octa-1,5-dien-3-ol (14). Bu3SnH (6.1 mL, 22.7 mmol) was added dropwise 
over 30 min via syringe pump to a stirred solution of alkyne 13 (1.89 g, 15.2 
mmol) and (PPh3)2PdCl2 (220 mg, 0.31 mmol, 2 mol%) in THF (50 mL) at 0 °C. The 
mixture was stirred at 0 °C for 30 min before the solvent was evaporated. Flash 
chromatography of the residue (silica, hexanes/EtOAc, 99:1 → 98:2) gave 
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product 14 as a colorless oil (3.72 g, 59 %). 1H NMR (400 MHz, CDCl3): δ  0.89 (t, J = 7.3, 15H), 0.97 
(t, J = 7.6, 3H), 1.25-1.36 (m, 6H), 1.45-1.55 (m, 6H), 1.56 (s, 1H), 2.01-2.11 (m, 2H), 2.28-2.34 (m, 2H), 
4.07-4.16 (m, 1H), 5.31-5.40 (m, 1H), 5.51-5.61 (m, 1H), 6.03 (dd, J = 19.1, 5.1, 1H), 6.17 (dd, J = 19.1, 
1.2, 1H); 13C NMR (100 MHz, CDCl3): δ  9.5, 13.7, 14.2, 20.7, 27.2, 29.1, 35.0, 74.7, 123.9, 127.8, 
135.0, 150.1; IR (film): ~  = 3329, 2957, 2924, 2872, 2852, 1601, 1463, 1418, 1363, 1418, 1376, 1338, 
1292, 1249, 1179, 1070, 1039, 988, 961, 872, 768, 688, 661; MS (EI): m/z (%) 359 (100), 303 (23), 251 
(6), 233 (4), 177 (27), 137 (35), 119 (7), 95 (2), 67 (7), 55 (4), 41 (5); HRMS (EI): m/z: calcd for 
C20H40OSn [M
]: 439.20067, found: 439.19998. 
(2Z,4E,8Z)-1-((tert-Butyldimethylsilyl)oxy)undeca-2,4,8-trien-6-yl acetate (16). CuTC (2.2 g, 11.7 
mmol) was added to a stirred solution of stannane 14 (3.23 g, 7.78 mmol) 
and alkenyl iodide 15 (2.73 g, 9.16 mmol) in degassed N-methyl-2-
pyrrolidone (20 mL) at 0 °C and the resulting mixture stirred at 0 °C for 1 h, 
during which time the color of the originally tan suspension turned deep red and later back tan/grey. 
The mixture was diluted with tert-butyl methyl ether (20 mL). Celite® (ca. 5 g) was added and the 
suspension stirred for 5 min, before it was filtered. The residue was carefully rinsed with tert-butyl 
methyl ether (ca. 100mL) and the combined filtrates were washed with water (100 mL) and aq. sat. 
NH4Cl (50 mL) before they were dried (Na2SO4) and concentrated in vacuo. Flash chromatography of 
the residue (silica, hexanes/EtOAc, 98:2 → 95:5) furnished the desired alcohol ( 2.5 g) which 
contained tin impurities. 1H NMR (400 MHz, CDCl3): δ  0.08 (s, 6H), 0.90 (s, 9H), 0.97 (t, J = 7.5, 3H), 
1.67 (d, J = 3.9, 1H), 2.02-2.11 (m, 2H), 2.26-2.39 (m, 2H), 4.16-4.25 (m, 1H), 4.36 (dd, J = 6.4, 1.6, 2H), 
5.31-5.39 (m, 1H), 5.50-5.62 (m, 2H), 5.72 (dd, J = 15.2, 6.2, 1H), 5.96-6.03 (m, 1H), 6.49 (ddt, J = 15.2, 
11.2, 1.2, 1H); 13C NMR (100 MHz, CDCl3): δ  –5.1, 14.2, 18.3, 20.7, 25.9, 35.2, 59.7, 71.9, 123.5, 
123.9, 125.3, 128.1, 131.3, 135.4, 136.7; IR (film): ~  = 3329, 2957, 2924, 2872, 2852, 1601, 1463, 
1418, 1376, 1338, 1292, 1249, 1179, 1070, 1039, 988, 961, 872, 768, 688, 661; MS (EI): m/z (%) 296 
(1), 279 (1), 239 (5), 227 (100), 211 (21), 197 (3), 169 (12), 147 (12), 133 (8), 115 (13), 105 (17), 95 
(75), 75 (65), 67 (32), 57 (5), 41 (29); HRMS (ESI): m/z: calcd for C17H32O2SiNa [M+Na
]: 319.20638, 
found: 319.20664. 
Ac2O (1 mL, 10.6 mmol) was added dropwise to a stirred solution of this 
impure product (2.5 g), Et3N (1.8 mL, 13 mmol) and DMAP (52 mg, 5 mol%) 
in CH2Cl2 (30 mL) at 0 °C. The mixture was stirred at 0 °C for 1 h, before the 
reaction was quenched with aq. sat. NaHCO3 (50 mL). The aqueous layer 
was extracted with tert-butyl methyl ether (3 x 50 mL), the combined extracts dried (Na2SO4) and 
concentrated in vacuo. Flash chromatography of the residue (silica, hexanes/EtOAc, 99:1 → 98:2) 
gave product 16 (2.45 g, 93 % over two steps). 1H NMR (400 MHz, CDCl3): δ  0.07 (s, 6H), 0.90 (s, 
9H), 0.56 (t, J = 7.5, 3H), 1.99-2.09 (m, 2H), 2.04 (s, 3H), 2.29-2.48 (m, 2H), 4.28-4.32 (m, 2H), 5.23-
5.35 (m, 2H), 5.45-5.66 (m, 3H), 5.93-6.00 (m, 1H), 6.48 (ddt, J = 15.2, 11.2, 1.1, 1H); 13C NMR (100 
MHz, CDCl3): δ  –5.1, 14.1, 20.7, 21.2, 18.3, 25.9, 32.3, 59.7 73.9, 122.8, 127.4, 127.9, 132.1, 132.2, 
134.8, 170.2; IR (film): ~  = 3016, 2957, 2930, 2857, 1739, 1370, 1231, 1079, 1018, 834, 774; MS (EI): 
m/z (%) 338 (0.2), 281 (1), 269 (3), 227 (4), 209 (4), 173 (1), 159 (4), 147 (26), 139 (2), 117 (100), 95 




dienoic acid (17). A solution of acetate 16 (1.37 g, 4.05 mmol) in THF (4 mL) 
was added dropwise to a solution of freshly prepared LDA (0.5 M in THF, 9.6 
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mL, 4.8 mmol) at –78 °C. After stirring for 5 min, a solution of TBSCl (1 M in THF/HMPA (3:2), 6 mL, 6 
mmol) was introduced and the resulting mixture warmed to ambient temperature and stirred for 4 h. 
For work up, the mixture was poured into aq. sat. NH4Cl (40 mL), the aqueous layer extracted with 
tert-butyl methyl ether (3 x 30 mL), and the combined extracts dried (Na2SO4) and concentrated in 
vacuo. 
The crude silyl ester thus obtained was dissolved in MeOH (20 mL) and the solution cooled to 0 °C 
before K2CO3 (615 mg, 4.4 mmol) was added. The resulting suspension was stirred at 0 °C for 30 min 
before it was poured into aq. sat. NH4Cl (50 mL + 50 mL water). The aqueous phase was extracted 
with tert-butyl methyl ether (3 x 50 mL), the combined organic layers were dried (Na2SO4) and 
concentrated in vacuo, and the residue purified by flash chromatography (silica, hexanes/EtOAc, 9:1 
→ 8:2) to give acid 17 (1.27 g, 93 %). 1H NMR (400 MHz, CDCl3): δ  0.06 (s, 6H), 0.90 (s, 9H), 0.95 (t, J 
= 7.5, 3H), 1.97-2.07 (m, 2H), 2.32-2.50 (m, 2H), 2.69-2.76 (m, 2H), 3.42-3.51 (m, 1H), 4.22-4.30 (m, 
2H), 5.22-5.52 (m, 5H), 5.53-5.61(m, 1H); 13C NMR (100 MHz, CDCl3): δ  –5.2, 14.2, 18.3, 20.4, 25.9, 
30.1, 37.2, 40.1, 59.6, 126.3, 129.4, 130.6, 130.6, 130.9, 132.6, 177.6; IR (film): ~  = 3014, 2957, 2929, 
2857, 1710, 1471, 1463, 1410, 1361, 1253, 1161, 1087, 1005, 965, 938, 834, 774, 716, 669; MS (EI): 
m/z (%) 305 (0.4), 281 (12), 263 (6), 237 (1), 206 (5), 161 (12), 147 (33), 137 (4), 105 (12), 91 (19), 75 
(100), 69 (9), 55 (7), 41 (12); HRMS (EI): m/z: calcd for C19H34O3SiNa [M+Na
]: 361.21694, found: 
361.21731. 
(4E,7Z)-tert-Butyl 3-((Z)-3-((tert-butyldimethylsilyl)oxy)prop-1-en-1-yl)deca-4,7-dienoate (18). 
2,4,6-Trichlorobenzoyl chloride (1.2 mL, 7.6 mmol) was added to the 
solution of acid 17 (1.30 g, 3.83 mmol) and Et3N (1.2 mL, 8.6 mmol) in 
toluene (40 mL). After stirring for 30 min, DMAP (500 mg, 4.1 mmol) and t-
BuOH (3 mL) were introduced and stirring continued for 48  h. The mixture 
was then poured into aq. sat. NaHCO3 (50 mL) and the aqueous layer extracted with pentane (3 x 20 
mL). The combined organic phases were dried (Na2SO4) and concentrated in vacuo, and the residue 
purified by flash chromatography (silica, hexane/tert-butyl methyl ether, 200:1 → 100:1) to furnish 
ester 18 (1.11 g, 73%). 1H NMR (400 MHz, CDCl3): δ  0.06 (s, 6H), 0.89 (s, 9H), 0.95 (t, J = 7.6, 3H), 
1.42 (s, 9H), 1.97-2.07 (m, 2H), 2.18-2.33 (m, 2H), 2.71-2.74 (m, 2H), 3.36-3.46 (m, 1H), 4.26 (dt, J = 
6.0, 1.7, 2H), 5.21-5.47 (m, 5H), 5.50-5.57 (m, 1H); 13C NMR (100 MHz, CDCl3): δ  –5.1, –5.1, 14.2, 
18.3, 26.0, 28.1, 30.1, 37.9, 41.7, 59.6, 80.3, 126.4, 128.8, 130.3, 131.1, 131.2, 132.5, 171.2; IR (film): 
~  = 3010, 2959, 2930, 2857, 1731, 1472, 1462, 1391, 1367, 1253, 1148, 1087, 1006, 965, 835, 775, 
717, 669; MS (EI): m/z (%) 337 (2), 321 (15), 305 (2), 281 (85), 263 (24), 237 (4), 206 (31), 189 (12), 
171 (18), 161 (44), 147 (100), 119 (19), 105 (19), 91 (27), 75 (90), 57 (26), 41 (8). HRMS (EI): m/z: 
calcd for C23H42O3SiNa [M+Na
]: 417.27954, found: 417.27964. 
(4E,7Z)-tert-Butyl 3-((Z)-3-hydroxyprop-1-en-1-yl)deca-4,7-dienoate. TBAF (1 M in THF, 1.2 mL, 1.2 
mmol) was added to a stirred solution of ester 18 (313 mg, 0.79 mmol) in 
THF (8 mL). After stirring for 1 h, all volatile materials were evaporated and 
the residue purified by flash chromatography (silica, hexanes/EtOAc, 9:5 → 
4:1) to give the title compound as a colorless syrup (210 mg, 95 %). 1H NMR 
(400 MHz, CDCl3): δ  0.95 (t, J = 7.5, 3H), 1.42 (s, 9H), 1.97-2.07 (m, 2H), 2.23 (br s, 1H), 2.24 (dd, J = 
15.5, 9.6, 1H), 2.39 (dd, J = 15.5, 5.2, 1H), 2.69-2.75 (m, 2H), 3.53-3.64 (m, 1H), 4.04 (dd, J = 12.5, 6.4, 
1H), 4.31 (ddd, J = 12.5, 7.9, 1.2, 1H), 5.25-5.49 (m, 5H), 5.67-5.75 (m, 1H); 13C NMR (100 MHz, CDCl3): 
δ  14.2, 20.4, 28.1, 30.1, 36.9, 41.2, 58.4, 80.9, 126.3, 128.9, 129.0, 131.2, 132.6, 134.0, 171.9; IR 
(film): ~  = 3431, 3009, 2966, 2934, 2875, 1727, 1456, 1429, 1392, 1367, 1298, 1254, 1146, 1019, 
S8 
 
966, 843, 728 MS (EI): m/z (%) 263 (1), 224 (2), 206 (30), 191 (5), 177 (22), 161 (10), 147 (57), 117 
(41), 95 (46), 91 (100), 79 (40), 67 (29), 57 (87), 41 (69), 29 (35); HRMS (ESI): m/z: calcd for 
C17H28O3Na [M+Na
]: 303.19307, found: 303.19294. 
(4E,7Z)-tert-Butyl 3-((Z)-3-bromoprop-1-en-1-yl)deca-4,7-dienoate (19). A solution of PPh3 (297 mg, 
1.1 mmol) in CH2Cl2 (1 mL) was added to the solution of (4E,7Z)-tert-butyl 3-
((Z)-3-hydroxyprop-1-en-1-yl)deca-4,7-dienoate (210 mg, 0.75 mmol) and 
CBr4 (373 mg, 1.1 mmol) in CH2Cl2 (5 mL) at 0 °C. The mixture was stirred at 0 
°C for 20 min before the reaction was quenched with aq. sat. NH4Cl (5 mL). 
The organic phase was extracted with tert-butyl methyl ether (3 x 10 mL), the combined organic 
layers were dried (Na2SO4) and concentrated in vacuo, and the residue purified by flash 
chromatography (silica, hexane/tert-butyl methyl ether, 99:1) to give bomide 19 (237 mg, 92 %). 1H 
NMR (400 MHz, CDCl3): δ  0.95 (t, J = 7.5, 3H), 1.42 (s, 9H), 1.95-2.07 (m, 2H), 2.22-2.40 (m, 2H), 2.73 
(brt, J = 6.5, 2H), 3.50-3.61 (m, 1H), 3.94-4.00 (m, 1H), 4.05-4.12 (m, 1H), 5.25-5.55 (m, 5H), 5.69-5.78 
(m, 1H); 13C NMR (100 MHz, CDCl3): δ  14.2, 20.4, 27.1, 28.1, 30.2, 37.1, 41.2, 80.6, 125.7, 126.2, 
129.6, 130.3, 132. 8, 135.9, 170.9; IR (film): ~  = 3009, 2967, 2933, 2874, 1727, 1455, 1392, 1367, 
1252, 1204, 1155, 1136, 1070, 1037, 966, 921, 869, 845, 766; MS (EI): m/z (%) 286 (1), 271 (2), 227 
(7), 207 (77), 189 (6), 161 (20), 147 (100), 133 (10), 119 (26), 105 (32), 95 (56), 79 (28), 67 (17), 57 
(61), 41 (45); HRMS (ESI): m/z: calcd for C17H27O2BrNa [M+Na
]: 365.10867, found: 365.10856. 
(4E,7Z)-tert-Butyl 3-((Z)-hex-1-en-4-yn-1-yl)deca-4,7-dienoate (20). A solution of 1-
propynylmagnesium bromide (0.5 M in THF, 2.8 mL, 1.4 mmol) was added 
to solid CuI (26.6 mg, 0.14 mmol) at –15 °C and the resulting mixture 
stirred at this temperature for 30 min before a solution of bromide 19 (234 
mg, 0.68 mmol) in THF (2 mL) was introduced. After stirring for 3 h at –10 
°C, the reaction was quenched with aq. sat. NH4Cl (25 mL). The aqueous layer was extracted with 
tert-butyl methyl ether (3 x 25 mL), the combined organic phases were dried (Na2SO4) and 
concentrated in vacuo, and the residue purified by flash chromatography (silica, hexane/tert-butyl 
methyl ether, 98:2) to give product 20 (202 mg, 98 %), which must be stored in the freezer. 1H NMR 
(400 MHz, CDCl3): δ  0.94 (t, J = 7.5, 3H), 1.42 (s, 9H), 1.76 (t, J = 2.6, 2H), 1.96-2.06 (m, 2H), 2.15-
2.35 (m, 2H), 2.71 (br t, J = 6.6, 2H), 2.89-2.95 (m, 2H), 3.40-3.50 (m, 2H), 5.22-5.50 (m, 6H); 13C NMR 
(100 MHz, CDCl3): δ  3.5, 14.2, 17.4, 20.4, 28.1, 30.2, 37.3, 41.6, 75.5, 77.2, 80.3, 125.6, 126.5, 128.8, 
130.9, 132.0, 132.4, 171.2; IR (film): ~  = 3010, 2966, 2920, 1729, 1456, 1431, 1367, 1293, 1256, 
1176, 1145, 1087, 1019, 966, 911, 845, 797, 705; MS (EI): m/z (%) 287 (1), 246 (4), 231 (4), 217 (11), 
187 (29), 177 (32), 171 (19), 157 (42), 143 (41), 131 (99), 117 (49), 105 (48), 91 (56), 79 (33), 67 (17), 
57 (100), 41 (65); HRMS (ESI): m/z: calcd for C20H30O2Na [M+Na
]: 325.21380, found: 325.21369. 
Undeca-1,9-diyn-1-yltrimethylsilane. Tf2O was added dropwise to a solution of non-7-yn-1-ol (2.2 g, 
15.7 mmol) and pyridine (1.35 mL, 16.7 mmol) in CH2Cl2 (60 ml) at –15 °C and 
the resulting mixture stirred at this temperature for 1h before it was diluted 
with hexane (60 mL) and filtered through Celite®, which was carefully rinsed 
with hexane. The combined filtrates were concentrated in vacuo (keeping the 
bath temperature < 20°C) to give the crude triflate as a colorless syrup (4.07 g, 
95 %), which was used in the next step without delay.  
nBuLi (1.6 M in hexane, 12 mL, 19.2 mmol) was slowly added to a stirred solution of ethynyl-
trimethylsilane (3.8 mL, 21 mmol) in THF (60 mL) at –78 °C and the resulting solution stirred at 0 °C 
for 30 min. The mixture was then cooled to –78 °C before a solution of the crude triflate (4.05 g, 14.9 
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mmol) in THF (15 mL) was introduced. The mixture was warmed to 0 °C, stirred for 1 h, the reaction 
quenched with aq. sat. NH4Cl (50 mL) and the aqueous phase extracted with hexane (3 x 50 mL). The 
combined extracts were dried (Na2SO4) and concentrated in vacuo, and the residue purified by flash 
chromatography (silica, hexane/tert-butyl methyl ether, 200:1) to give the title compound as a 
colorless syrup (2.90 g, 84%). 1H NMR (400 MHz, CDCl3): δ  0.14 (s, 9H), 1.34-1.42 (m, 4H), 1.43-1.52 
(m, 4H), 1.77 (t, J = 2.6, 3H), 2.08-2.15 (m, 2H), 2.21 (t, J = 7.1, 2H); 13C NMR (100 MHz, CDCl3): δ  
0.2, 3.4, 18.6, 19.8, 28.3 (2C), 28.5, 28.9, 75.4, 79.2, 84.3, 107.6; IR (film): ~  = 2935, 2859, 2174, 
1248, 837, 758, 697 cm1; MS (EI): m/z (%) 220 (2), 205 (12), 192 (3), 177 (9), 163 (3), 145 (14), 131 
(11), 117 (6), 109 (7), 97 (13), 83 (9), 73 (100), 67 (6), 59 (35), 53 (5), 43 (6); HRMS (EI): m/z: calcd for 
C14H24Si [M
]: 220.16473, found: 220.16494. 
Undeca-1,9-diyne. K2CO3 (2.8 g, 20.3 mmol) was added to solution of undeca-1,9-diyn-1-
yltrimethylsilane (913 mg, 4.14 mmol) in methanol (50 mL) and the suspension 
stirred for 4 h before it was poured into aq. sat. NH4Cl (100 mL). The aqueous layer 
was extracted with pentane (3 x 50 mL) and the combined extracts dried (Na2SO4) 
and concentrated in vacuo to give the title compound as a colorless oil which was 
pure enough for further use (601 mg, 98%). 1H NMR (400 MHz, CDCl3): δ  1.35-1.44 
(m, 4H), 1.45-1.57 (m, 4H), 1.77 (t, J = 2.6, 3H), 1.93 (t, J = 2.6, 1H), 2.09-2.15 (m, 2H), 2.18 (dt, J = 7.0, 
2.6, 2H); 13C NMR (100 MHz, CDCl3): δ  3.4, 18.3, 18.7, 28.3, 28.3, 28.4, 28.9, 68.1, 75.4, 79.2, 84.6; 
IR (film): ~  = 3298, 2934, 2859, 1459, 1434 cm1; MS (EI): m/z (%) 147 (1), 133 (6), 119 (22), 105 (92), 
91 (100), 79 (67), 67 (57), 53 (49), 41 (58), 27 (31); HRMS (EI): m/z: calcd for C11H16 [M
]: 148.12520, 
found: 148.12517. 
Methyl dodeca-2,10-diynoate. nBuLi (1.6 M in hexane, 4 mL, 6.4 mmol) was slowly added to a stirred 
solution of undeca-1,9-diyne (917 mg, 6.2 mmol) in THF (20 mL) at –78 °C and 
the resulting mixture stirred at this temperature for 30 min before methyl 
chloroformate (500 µL, 6.4 mmol) was introduced. The resulting mixture was 
stirred at –78 °C for 3h before the reaction was quenched with aq. sat. NH4Cl 
(50 mL). The aqueous phase was extracted with tert-butyl methyl ether (3 x 30 
mL), the combined extracts were dried (Na2SO4) and concentrated in vacuo, 
and the residue was purified by flash chromatography (silica, hexane/tert-butyl methyl ether, 99:1 → 
95:5) to afford the title compound as a colorless syrup (1.06 g, 83%). 1H NMR (400 MHz, CDCl3): δ  
1.36-1.43 (m, 4H), 1.44-1.52 (m, 2H), 1.54-1.63 (m, 2H), 1.77 (t, J = 2.5, 3H), 2.08-2.15 (m, 2H), 2.33 (t, 
J = 7.1, 2H), 3.75 (s, 3H); 13C NMR (100 MHz, CDCl3): δ  3.4, 18.6, 18.6, 27.4, 28.2, 28.3, 28.8, 52.5, 
72.9, 75.5, 79.1, 89.8, 154.2; IR (film): ~  = 2936, 2859, 2234, 1712, 1434, 1248, 1075, 751; MS (EI): 
m/z (%) 205 (4), 191 (14), 175 (11), 163 (31), 147 (33), 131 (37), 124 (21), 119 (50), 111 (13), 105 
(100), 98 (11), 91 (82), 79 (64), 67 (64), 59 (27), 53 (62), 41 (61), 27 (29); HRMS (ESI): m/z: calcd for 
C13H18O2Na [M
  Na]: 229.11990, found: 229.12012. 
tert-Butyl-3-oxo-2-((5Z,8E,11Z)-tetradeca-5,8,11-trien-2-yn-7-yl)tetradeca-4,12-diynoate (21). A 
solution of ester 20 (260 mg, 0.86 mmol) in THF (0.5 mL) was 
slowly added to a stirred solution of freshly prepared LDA (0.5 
M in THF, 1.67 mL, 0.84 mmol) at –78 °C. The mixture was 
stirred at this temperature for 25 min before a solution of 
methyl dodeca-2,10-diynoate (225 mg, 1.10 mmol) in THF (0.5 
mL) was introduced. Stirring was continued at –78 °C for 3 h 
and for 1 h at 0 °C. The reaction was quenched with aq. sat. NH4Cl (5 mL), the aqueous layer 
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extracted with tert-butyl methyl ether (3 x 10 mL), the combined organic phases were dried (Na2SO4) 
and concentrated in vacuo, and the residue was purified by flash chromatography (silica, 
hexane/tert-butyl methyl ether, 100:1) to give product 21 (304 mg, 76 %). This product can be stored 
at –20°C for short periods of time. It exists as a mixture of (at least) three species (keto- and enol 
forms) in a ratio of  3:3:4 (NMR). 1H NMR (400 MHz, CDCl3): δ  0.93 (t, J = 7.5, 0.3 x 3H), 0.93 (t, J = 
7.5, 0.3 x 3H), 0.94 (t, J = 7.5, 0.4x3H), 1.35-1.54 (m, 6H), 1.41 (s, 0.3 x 3H), 1.42 (s, 0.3 x 3H), 1.48 (s, 
0.4 x 3H), 1.54-1.66 (m, 2H), 1.95-2.07 (m, 2H), 2.08-2.15 (m, 2H), 2.37 (dt, J = 7.0, 1.5, 1H), 2.44 (t, J = 
7.1, 1H), 2.61-2.76 (m, 2H), 2.84-3.04 (m, 2H), 3.40 (dd, 9.6, 5.7, 0.6H), 3.75-3.88 (m, 0.6H), 3.28-3.35 
(m, 0.4H), 5.18-5.61 (m, 5.6H), 5.69-5.77 (m, 0.4H), 12.51 (s, 0.3H); 13C NMR (100 MHz, CDCl3, 
resolved signals of the ketone/enol mixture): δ  3.4, 3.4, 3.5, 14.2, 14.2, 17.5, 17.6, 18.6, 18.7, 19.0, 
19.5, 20.4, 27.5, 27.8, 27.9, 28.0, 28.2, 28.3, 28.3, 28.4, 28.6, 28.8, 28.9, 30.1, 30.1, 30.2, 40.1, 40.1, 
40.3, 66.5, 66.8, 75.2, 75.3, 75.4, 75.5, 75.5, 75.5,, 77.1, 79.0, 79.1, 80.1, 80.3, 82.0, 82.3, 96.6, 96.6, 
100.0, 111.2, 125.1, 126.1, 126.2, 126.7, 127.1, 127.2, 128.1, 128.3, 129.0, 129.2, 130.7, 130.9, 131.6, 
131.9, 132.2, 132.6, 132.6, 152.5, 166.2, 166.3, 172.1, 181.3, 181.4; IR (film): ~  = 3008, 2934, 2859, 
2212, 1733, 1676, 1631, 1587, 1456, 1392, 1368, 1250, 1148, 1098, 1035, 966, 910, 846, 732, 679; 
HRMS (EI): m/z: calcd for C32H44O3Na [M+Na
]: 499.31827, found: 499.31808. 
6-(Non-7-yn-1-yl)-2-oxo-3-((5Z,8E,11Z)-tetradeca-5,8,11-trien-2-yn-7-yl)-2H-pyran-4-yl acetate (23). 
A solution of XPhosAuNTf2 (22) (0.7 mg, 5 mol%) and compound 
21 (6.5 mg, 13.6 µmol) in MeNO2/HOAc (350 µL, 4:1) was stirred 
for 14 h at ambient temperature. For work up, the solvents were 
distilled off under vacuum while cooling the mixture to 0 °C. The 
residue was dissolved in CH2Cl2 (1 mL), and Et3N (30 µL) and Ac2O 
(15 µL) were added at 0 °C. After stirring for 30 min at 0 °C, the reaction was quenched with aq. sat. 
NaHCO3 (3 mL), the aqueous layer extracted with tert-butyl methyl ether (3 x 5 mL), the combined 
organic phases were dried (Na2SO4) and concentrated in vacuo, and the residue quickly passed 
through a short pad of silica, eluting with a gradient of hexane/tert-butyl methyl ether (99:1 → 95:5) 
to give product 23 as a colorless syrup (4.6 mg, 73 %). This product can be stored at –20°C only for 
short periods of time. 1H NMR (400 MHz, CDCl3): δ  0.94 (t, J = 7.5, 3H), 1.29-1.51 (m, 6H), 1.59-1.68 
(m, 2H), 1.76 (t, J = 2.6, 3H) 1.77 (t, J = 2.5, 3H), 1.97-2.06 (m, 2H), 2.08-2.15 (m, 2H), 2.29 (s, 3H), 
2.44 (brt, J = 7.7, 2H), 2.73 (br t, J = 6.5, 2H), 2.83-3.00 (m, 2H), 4.44-4.51 (m, 2H), 5.25-5.34 (m, 1H), 
5.36-5.63 (m, 3H), 5.59-5.67 (m, 1H), 5.73-5.81 (m, 1H), 5.89 (s, 1H); 13C NMR (100 MHz, CDCl3): δ  
3.4, 3.5, 14.2, 17.4, 18.6, 20.5, 21.0, 26.6, 28.1, 28.5, 28.8, 30.1, 33.5, 36.8, 75.6, 75.6, 76.9, 79.1, 
101.6, 116.5, 126.3, 126.5, 128.9, 129.4, 129.6, 132.6, 158.1, 163.7, 163.7, 167.1; IR (film): ~  = 3011, 
2932, 2858, 1778, 1718, 1649, 1583, 1432, 1368, 1180, 1012, 1009, 972, 910, 876, 801, 728; MS (EI): 
m/z (%): 462 (19), 420 (63), 391 (16), 377 (27), 367 (48), 351 (70), 341 (32), 325 (100), 311 (9), 297 
(11), 270 (13), 227 (16), 201 (20), 173 (35), 159 (66), 131 (26), 145 (20), 117 (28), 109 (33), 91 (49), 69 
(53), 55 (56), 43 (84). HRMS (ESI): m/z: calcd for C30H38O4Na [M+Na
]: 485.26623, found: 485.26654. 
 (Z)-2-((1E,4Z)-Hepta-1,4-dien-1-yl)-16-oxo-15-oxabicyclo[12.2.2]octadeca-1(17),3,14(18)-trien-6-
yn-17-yl acetate (25). Dried MS 5Å powder (100 mg) was added to a solution of 
compound 23 (7.8 mg, 17 µmol) in toluene (17 mL) and the resulting suspension 
stirred for 30 min before a solution of complex 24 (10 mM in toluene, 85 µL, 0.85 
µmol, 5 mol%) was introduced. After stirring for 30 min at ambient temperature, the 
mixture was filtered through a pad of Celite®, which was thoroughly rinsed with tert-
butyl methyl ether. The combined filtrates were concentrated in vacuo and the 
residue purified by flash chromatography (silica, hexane/tert-butyl methyl ether, 
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98:2 → 95:5) to give cycloalkyne 25 (6.1 mg, 88 %, ca. 1:1 mixture of atropisomers). 1H NMR (500 
MHz, CDCl3): δ  0.94 (t, J = 7.5, ½·3H), 0.94 (t, J = 7.5, ½·3H), 1.06-1.38 (m, 5H), 143-1.55 (m, 1H), 
1.66-1.87 (m, 2H), 1.97-2.05 (m, 2H), 2.05-2.18 (m, 2H), 2.20-2.27 (m, ½H), 2.26 (s, ½·3H), 2.28-2.36 
(m, ½H), 2.36 (s, ½·3H), 2.61-2.76 (m, 4H), 2.85-2.93 (m, ½H), 3.06-3.15 (m, ½H), 4.26 (brt, J = 7.0, 
½H), 4.60-4.65 (m, ½H), 5.24-5.32 (m, 1H), 5.37-3.49 (m, 2½H), 5.51-5.54 (m, 1H), 5.78 (brdd, J = 10.3, 
7.2, ½H), 5.83 (ddt, J = 15.4, 7.6, 1.6, ½H), 5.91 (brdd, J = 10.3, 6.3, ½H), 6.02 (s, ½H), 6.03 (s, ½H); 13C 
NMR (125 MHz, CDCl3): δ  14.2, 14.2, 17.8, 18.2, 18.6, 18.7, 20.4, 20.5, 20.9, 21.3, 24.8, 25.0, 27.7, 
27.9, 28.3, 28.7, 28.9, 29.0, 30.1, 30.1, 34.6, 35.1, 35.8, 36.3, 76.9, 77.3, 79.1, 79.6, 101.9, 103.3, 
117.6, 118.0, 125.5, 126.1, 126.3, 126.4, 129.2, 129.2, 129.4, 130.3, 131.7, 131.7, 132.6, 132.6, 156.3, 
158.8, 162.5, 163.3, 163.7, 164.7, 166.7, 167.0; IR (film): ~  = 3011, 2929, 2857, 1779, 1711, 1647, 
1582, 1460, 1432, 1368, 1331, 1257, 1176, 1111, 1070, 1037, 1010, 968, 896, 872, 788, 727; MS (ESI): 
m/z (%) 341.2 (M+Na), 839.4 (2M+Na); HRMS (EI): m/z: calcd for C26H32O4Na [M+Na
]: 431.21928, 
found: 431.21960. 
 Neurymenolide A Acetate (2). H2 was bubbled through a mixture containing cycloalkyne 25 (5.5 mg, 
13.5 µmol), Lindlar catalyst (5.5 mg), quinoline (20 µL) in EtOAc/1-hexene (2 mL, 1:1) 
for 10 min. The suspension was then stirred under H2 (1 atm) for 1 h before it was 
filtered through a pad of Celite®, which was thoroughly rinsed with tert-butyl methyl 
ether. The combined filtrates were concentrated in vacuo and the residue purified by 
flash chromatography (silica, hexane/tert-butyl methyl ether, 98:2 → 95:5) to provide 
neurymenolide A acetate (2) (4.7 mg, 84 %) as a  2:3 mixture of atropisomers. 1H 
NMR (500 MHz, CDCl3): δ 0.94 (t, J = 7.5, 2/5x3H), 0.95 (t, J = 7.5, 3/5x3H), 1.02-1.41 (m, 6H), 1.54-
1.71 (m, 1H), 1.71-1.98 (3H), 2.02 (qi, J = 7.4, 2H), 2.20-2.25 (m, 2/5H), 2.22 (s, 3/5x3H), 2.25-36 (m, 
3/5H), 2.34 (s, 2/5x3H), 2.37-4.48 (m, 1H), 2.63-2.75 (m, 1H), 2.71-2.77 (m, 2H), 2.77-2.88 (m, 1H), 
4.12-4.18 (m, 2/5H), 4.48-4.53 (m, 3/5H), 5.19-5.61 (m, 7+1/5H), 5.64-5.70 (m, 2/5H), 5.76-5.82 (m, 
2/5H), 5.98 (3/5H), 6.01 (2/5H); 13C NMR (125 MHz, CDCl3): δ  14.2, 14.3, 20.4, 20.5, 20.9, 21.2, 24.2, 
25.5, 25.8, 26.2, 26.4, 26.9, 26.9, 27.1, 27.1, 27.2, 27.4, 27.6, 30.1 (x2), 33.7, 33.8, 37.1, 37.5, 102.5, 
103.7, 116.9, 117.3, 126.3, 126.3, 127.2, 127.5, 129.2, 129.3, 129.4, 129.4, 129.8, 129.8, 129.8, 130.0, 
130.1, 130.2, 132.6, 132.6, 157.2, 158.5, 162.1, 163.7, 164.2, 164.9, 166.7, 167.1; IR (film): ~  = 3009, 
2927, 2854, 1778, 1714, 1647, 1580, 1461, 1435, 1367, 1274, 1178, 1111, 1043, 1011, 967, 871, 788, 
726, 698; MS (EI): m/z (%) 410 (69), 368 (100), 351 (11), 339 (24), 325 (14), 313 (10), 299 (96), 273 
(33), 257 (11), 243 (7), 229 (7), 215 (8), 199 (13), 187 (10), 175 (13), 159 (15), 145 (15), 133 (16), 117 
(22), 105 (23), 91 (42), 79 (33), 69 (48), 55 (42), 43 (71); HRMS (EI): m/z: calcd for C26H34O4Na 




Figure S2. Preparative HPLC (Shimadzu LC-8A/10A, YMC (150 mm,  20 mm) ODS-A 5 µm, 
MeCN/H2O (9:1), 15 mL/min) allowed the two atropisomers of 2 to be separated; however, they 
equilibrate quickly in solution as evident from the HPLC traced recorded 6 min, 1 h, and 16 h after 




Table S1. Comparison of the 
13
C NMR data (CDCl3) of synthetic neurymenolide A acetate (2) with the reported 
data of the authentic sample.
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Synthetic sample Literature Data 
 Major isomer Minor isomer 
δ δ Δ δ δ Δ δ 
14.2    14.2 0 
14.3 14.2 0.1   
20.4 20.5 -0.1   
20.5   20.5 0 
20.9   20.9 0 
21.2 21.2 0   
24.2   25.5 -1.3 
25.5 25.5 0   
25.8   25.8 0 
26.2 26.2 0   
26.4 26.4 0   
26.9 26.9 0   
26.9   26.9 0 
27.1   27.1 0 
27.1 27.1 0   
27.2 27.2 0   
27.4   27.4 0 
27.6   27.6 0 
30.1   30.0 0.1 
30.1 30.0 0.1   
33.7 33.7 0   
33.8   33.8 0 
37.1 37.1 0   
37.5   37.5 0 
102.5   102.5 0 
103.7 103.7 0   
116.9   116.9 0 
117.3 117.3 0   
126.3 126.3 0   
126.3   126.3 0 
127.2 127.2 0   
127.5   127.5 0 
129.2 129.3 -0.1   
129.3   129.4 -0.1 
129.4   129.4 0 
129.4 129.4 0   
129.8   129.7 0.1 
129.8   129.8 0 
129.8 129.8 0   
130.0 130.0 0   
130.1   130.1 0 
130.2 130.2 0   
132.6 132.5 0.1   
132.6   132.6 0 
157.2   157.2 0 
158.5 158.5 0   
162.1   162.1 0 
163.7 163.7 0   
164.2 164.2 0   
164.9   165.0 -0.1 
166.7 166.6 0.1   





Neurymenolide A (1). K2CO3 (0.5 mg, 3.6 µmol) was added to solution of 2 (0.9 mg, 4.1 mmol) in 
methanol (0.5 mL) at 0 °C and the suspension stirred at this temperature for 30 min. 
The mixture was poured into aq. sat. NH4Cl (5 mL), the aqueous layer quickly extracted 
with tert-butyl methyl ether (3 x 5 mL), and the combined organic phases were dried 
(Na2SO4) and concentrated in vacuo to give crude neurymenolide A (1) which was pure 
enough to ensure identity with the natural product.4 Attempts to remove traces of 
impurities from the crude material lead to decomposition. 1H NMR (500 MHz, CDCl3): δ 
 0.95 (t, J = 7.5, 3H), 1.02-1.42 (m, 6H), 1.50-1.70 (m, 1H), 1.75-2.04 (m, 3H), 1.92-2.08 (m, 2H), 2.22-
2.35 (m, 1H), 2.50-2.59 (m, 1H), 2.59-2.67 (m, 1H), 2.71-2.81 (m, 2H), 2.81-2.91 (m, 1H), 4.55-4.59 (m, 
1H), 5.17-5-5.48 (m, 4H), 5.57-5.74 (m, 4H), 5.82 (s, 1H), 6.39 (s, 1H); 13C NMR (125 MHz, CDCl3): δ  
14.2, 20.5, 25.6, 26.6, 26.9, 27.0, 27.1, 27.7, 30.0, 33.5, 36.5, 101.3, 103.8, 125.9, 126.6, 126.9, 129.4, 
129.9, 131.0, 133.0, 135.5, 164.6, 165.1, 165.1; MS (EI): m/z (%) 368 (80), 353 (5), 339 (16), 325 (8), 
313 (8), 299 (100), 273 (19), 257 (8), 243 (6), 229 (6), 215 (8), 201 (9), 187 (10), 175 (14), 159 (16), 
145 (19), 133 (24), 117 (25), 105 (34), 91 (61), 79 (54), 69 (71), 55 (73), 41 (89); MS (ESI): 391.2 (100%, 
M+Na), 759.5 (37%, 2M+Na); HRMS (ESI): m/z: calcd for C24H32O3Na [M+Na
]: 391.22436, found: 
391.22408. 
 
Table S2. Comparison of the 
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δ Δ δ 
Synthetic sample (125 MHz) Authentic sample (150 MHz)  
14.2 14.2 0 
20.5 20.5 0 
25.6 25.6 0 
26.6 26.6 0 
26.9 26.9 0 
27.0 27 0 
27.1 27.1 0 
27.7 27.7 0 
30.0 30 0 
33.5 33.5 0 
36.5 36.5 0 
101.3 101.4 -0.1 
103.8 103.9 -0.1 
125.9 125.9 0 
126.6 126.6 0 
126.9 127 -0.1 
129.4 129.4 0 
129.9 129.9 0 
131.0 131 0 
133.0 132.9 0.1 
135.5 135.2 0.3 
164.7 164.7 0 
165.1 165.1 0 
165.1 165.1 0 
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